Results for
Biohaven
1 Results-
Pfizer to spend $11.6B on migraine treatment maker Biohaven
Pfizer is spending more than $11.6 billion to buy the remaining portion of migraine treatment maker Biohaven Pharmaceuticals it does not already ... Financial Markets
You’ve viewed 1 of 1 results